The British Prime Minister’s controversial idea to put obese people to work

The British Prime Minister’s controversial idea to put obese people to work
The British Prime Minister’s controversial idea to put obese people to work

Obesity-related illnesses cost the National Health Service £11 billion a year.

A test program is planned

In the view of the British government, supported by Prime Minister Keir Starmer, it is time to “think differently” to alleviate pressure on the health system. The member and leader of the Labor Party believes that the British National Health Service (NHS) should offer unemployed obese people concrete solutions to help them return to the job market.

This drug that made Elon Musk lose 13 kilos, and caused Coca-Cola to fall on the stock market

Health Secretary Wes Streeting says some drugs could be ‘life-changing’ for people, while obesity-related illnesses cost the UK £11bn a year NHS.

Initially, it is the drug Mounjaro, marketed by the American company Eli Lilly and Company, which should be offered to obese unemployed people. This pharmaceutical group, the world leader in this sector in terms of market capitalization (850 billion dollars), offers this drug capable of causing obese people (thus having a BMI greater than 30) to lose on average 15% of their weight. This is a drug similar to Ozempic or Wegovy, anti-diabetics marketed by the Danish company Novo Nordisk, which have enormous success with the public for their appetite suppressant aspect, which has sometimes caused shortages.

The company will also invest more than 279 million pounds sterling (333 million euros) in the trial, which will examine whether the use of the drug will reduce the number of unemployed. Nearly 250,000 people are expected to receive Mounjaro over the next three years, policymakers said. David A Ricks, chairman and CEO of Lilly, was delighted. “We welcome the opportunity to work in partnership with the UK Government to tackle and prevent disease and accelerate innovation to advance care delivery models.”he said.

“Critical unavailability” in Belgium: an anti-diabetic drug (and appetite suppressant) from Novo Nordisk out of stock

According to the BBC, Wes Streeting added that these drugs could also benefit the economy, reducing the number of sick days caused by obesity. “Illnesses caused by obesity cause people to take four extra sick days on average per year, while many more are forced out of work altogether.he affirmed, adding without empathy that individuals will always have to remain responsible for adopting “healthier lives, as the NHS cannot always be expected to foot the bill for unhealthy lifestyles.”

-

-

PREV why the probable sinking of a nuclear submarine is bad news for Beijing
NEXT Global warming forces Italy and Switzerland to redraw their common border